We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+13.4%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$10.9B
AUM Growth
+$1.67B
(+18%)
Cap. Flow
+$806M
Cap. Flow
% of AUM
7.42%
Top 10 Holdings %
Top 10 Hldgs %
14.27%
Holding
678
New
211
Increased
171
Reduced
126
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ERF
Enerplus Corporation
ERF
|
+$91.2M |
| 2 |
TE Connectivity
TEL
|
+$81.6M |
| 3 |
Palo Alto Networks
PANW
|
+$78.9M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$75.6M |
| 5 |
Honeywell
HON
|
+$70.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$113M |
| 2 |
AbbVie
ABBV
|
+$110M |
| 3 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
+$88.1M |
| 4 |
SPLK
Splunk Inc
SPLK
|
+$70.1M |
| 5 |
Synopsys
SNPS
|
+$64.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.5% |
| 2 | Technology | 22.75% |
| 3 | Industrials | 9.82% |
| 4 | Energy | 8.34% |
| 5 | Consumer Discretionary | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Madrigal Pharmaceuticals
MDGL
$11.8B
| $5.26M | 0.05% |
+19,700
| New | +$4.64M |
|
352
Lantheus
LNTH
$6.6B
| $5.23M | 0.05% |
84,000
| – | – |
|
353
ScottsMiracle-Gro
SMG
$3.61B
| $5.21M | 0.05% |
+69,813
| New | +$4.34M |
|
354
Krispy Kreme
DNUT
$557M
| $5.18M | 0.05% |
339,873
+250,936
| +282% | +$3.35M |
|
|
SLN
355
Silence Therapeutics
SLN
$554M
| $5.15M | 0.05% |
238,380
+189,108
| +384% | +$4.11M |
|
356
TriNet
TNET
$3.06B
| $5.13M | 0.05% |
+38,704
| New | +$4.7M |
|
357
NVIDIA
NVDA
$5.3T
| $5.12M | 0.05% |
56,660
-311,360
| -85% | -$22.6M |
|
358
RingCentral
RNG
$5.18B
| $5.1M | 0.05% |
146,792
-12,638
| -8% | -$425K |
|
359
BioNTech
BNTX
$22.9B
| $5.05M | 0.05% |
54,735
-72,825
| -57% | -$6.98M |
|
|
NUVL
360
DELISTED
Nuvalent
NUVL
| $4.92M | 0.05% |
65,492
| – | – |
|
361
Telephone and Data Systems
TDS
$4.1B
| $4.88M | 0.04% |
304,527
+33,527
| +12% | +$572K |
|
362
Endava
DAVA
$154M
| $4.87M | 0.04% |
127,931
| – | – |
|
363
Fortrea Holdings
FTRE
$1.68B
| $4.85M | 0.04% |
120,925
-65,186
| -35% | -$2.26M |
|
364
Astera Labs
ALAB
$57.5B
| $4.82M | 0.04% |
+64,945
| New | +$4.81M |
|
365
Bilibili
BILI
$7.81B
| $4.71M | 0.04% |
+420,246
| New | +$4.41M |
|
366
Knowles
KN
$3.36B
| $4.7M | 0.04% |
+291,755
| New | +$4.78M |
|
367
Cogent Biosciences
COGT
$7.14B
| $4.69M | 0.04% |
698,378
-92,106
| -12% | -$569K |
|
|
SLNO
368
DELISTED
Soleno Therapeutics
SLNO
| $4.56M | 0.04% |
106,460
-93,540
| -47% | -$4.23M |
|
369
Charles River Laboratories
CRL
$12.7B
| $4.55M | 0.04% |
+16,780
| New | +$4.01M |
|
|
DAWN
370
DELISTED
Day One Biopharmaceuticals
DAWN
| $4.5M | 0.04% |
272,538
| – | – |
|
|
BLD
371
DELISTED
TopBuild
BLD
| $4.42M | 0.04% |
10,038
+4,168
| +71% | +$1.63M |
|
372
Astrana Health
ASTH
$1.69B
| $4.37M | 0.04% |
+103,975
| New | +$4.06M |
|
373
Bausch Health
BHC
$2.21B
| $4.34M | 0.04% |
+409,333
| New | +$3.58M |
|
|
374
Synopsys
SNPS
$77.7B
| $4.25M | 0.04% |
7,441
-117,326
| -94% | -$64.6M |
|
375
Jackson Financial
JXN
$9.03B
| $4.22M | 0.04% |
+63,849
| New | +$3.47M |
|
Similar funds
TCIIS
UIM
VAI
KK
Woodline Partners's Q1 2024 Portfolio in Review
As of Q1 2024, Woodline Partners held 678 positions worth $10.9B, up 18% from $9.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Woodline Partners deployed $806M of net new capital in Q1 2024, opening 211 new positions and adding to 171 existing holdings. Its largest new stake was Enerplus Corporation: 5,602,613 shares worth $110M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $110M trimmed.
- Woodline Partners's largest Q1 2024 buy was Enerplus Corporation: 5,602,613 shares worth $110M.
- Woodline Partners added most to TE Connectivity in Q1 2024, an estimated $81.6M increase.
- Woodline Partners's biggest Q1 2024 reduction was AbbVie, cutting an estimated $110M.
- Woodline Partners fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $113M.
- Woodline Partners's ten largest holdings make up 14% of its $10.9B portfolio in Q1 2024.
- Woodline Partners opened 211 new positions and closed 150 in Q1 2024.
- Woodline Partners's portfolio value rose 18% quarter-over-quarter to $10.9B.
Based on Woodline Partners's 13F filing for Q1 2024, filed 15 May 2024.